A new therapy for treating Type 1 diabetes | Harvard Stem Cell Institute (HSCI)
Engineering islets from stem cells for advanced therapies of diabetes | Nature Reviews Drug Discovery
Vertex buys ViaCyte for $320M, clearing out T1D competition
Why stem cells may be the answer to curing Type 1 diabetes
Frontiers | Clinical Translational Potentials of Stem Cell-Derived Extracellular Vesicles in Type 1 Diabetes
Frontiers | Engineering Islets From Stem Cells: The Optimal Solution for the Treatment of Diabetes?
ViaCyte's Future 'Functional Diabetes Cure' for Diabetes
Applications of iPSC-derived beta cells from patients with diabetes
Vertex snaps up diabetes stem cell rival | Nature Biotechnology
Vertex – type 1 diabetes vs stem cell therapy - The Boar
Clinical Trial for Novel Investigational Treatment of Type 1 Diabetes Open for Enrollment in Miami | Regenerative Medicine Foundation
Vertex buys developer of preclinical cell therapy for Type 1 diabetes for $950M - MedCity News
Stem Cell Therapy for Type 1 Diabetes: Patient Achieved Insulin Independence on Day 270
Vertex: New Stem Cell Based Type 1 Diabetes Treatment Shown Effective in First Patient - DSM
Vertex Pharmaceuticals' $950 Million Bet on Curing Type 1 Diabetes Could Have an Astronomical Payoff | The Motley Fool
Vertex spends nearly $1bn on Semma's unproven diabetes cell tech | Evaluate
Vertex: Trial of New Type 1 Diabetes Cell Therapy Put on Hold - DSM
Vertex Type 1 Diabetes Research Stirs Hope for Stem Cell-Based 'Cure'
A Cure for Type 1 Diabetes? For One Man, It Seems to Have Worked. - The New York Times
International Medical Students' Research Association - The new remarkable treatment for Type 1 diabetes! Type 1 diabetes (T1D) is a chronic condition in which the pancreas produces little or no insulin. Insulin
JDRF Report: Vertex Has a New Horizon: Curing Type 1 Diabetes
